Abstract:Objective To investigate the incidence and clinical features of mixed infections in children with Mycoplasma pneumoniae (MP) pneumonia.Method A total of 201 cases diagnosed as MP pneumonia were investigated for mixed infections by sputum bacterial culture,respiratory virus antigen detection and serum Chlamydia pneumoniae antibody test.For those with the indications for bronchoscopy,we also did bronchoalveolar lavage and lavage bacterial culture. Result A high incidence ( 103/201,51.2％ ) of mixed infections in children with MP pneumonia was revealed. The most frequent co-infected pathogen was Chlamydia pneumoniae (52,25.9％),followed by viruses ( 29,14.4％ ),and bacteria( 22,10.9％ ). Among viruses,respiratory syncytial virus was the most common (17,8.5％),followed by adenovirus( 6,3.0％ ),parainfluenza virus type Ⅲ (4,2.0％ ) and influenza virus type B ( 2,1.0％ ).Sputum bacterial culture was positive in 14/201 (7.0％) cases,Streptococcus pneumonia being most common(6,3.0％ ).BALF culture yielded positive results in 11.6％ (8/69),Streptococcus pneumonia was also common(5,7.3％ ).Among 29 cases with MP and virus coinfection,26 were younger than 3 years (89.7％ ),while for MP and Chlamydia pneumoniae coinfection,most of them were older than 3 years (40/52,76.9％ ). Compared with non-mixed infections,those with mixed infections had longer fever duration (24.5％ and 40.8％ longer than 10 d),more frequently developed pleural effusion ( 11.2％,23.3％ ) and large area of shadow in chest imaging (35.7％,51.5％ ).White blood cell[ ( 14.28 ±4.99) × 109/L],Creactive protein (CRP) [69(32.5-99.5) mg/L] and neutrophil ratio in BALF[0.86(0.63-0.91 ) ] were much higher in children with mixed bacterial infections than that in non-mixed infections [ (9.06 ± 3.47) ×109/L,3 (0-31.0) mg/L,0.44 (0.03-0.88 ) ].But no significant difference was found in peripheral blood neutrophil proportion between mixed bacterial infections (0.38 ± 0.25 ) and non-mixed infections(0.51 ±0.19).Conclusion More than half of cases with MP pneumonia had mixed infections,most commonly caused by Chlamydia pneumonia followed by viruses.The incidence of mixed infections with bacteria was low.Mixed infections with virus were more common in young children,while mixed infection with Chlamydia pneumoniae was more common in older ones.Bacterial infections should be paid more attention,especially those caused by Streptococcus pneumoniae,for those with high peripheral white blood cell counts,high CRP levels and high proportion of neutrophils in BALF.

Clarithromycin Combined Singulair Treatment of Mycoplasma Infection-induced Chronic Cough

Azithromycin Sequential Therapy Combined with Nebulization Inhalation of Budesonide and Combivent in Treating Mycoplasma Pneumonia in 40 Children Cases

Clinical Observation of Montelukast Prevention for Wheezing Infants and Young Children after Brochiolitis

Clinical Efficacy of Azithromycin in Treatment of Children’s Mycoplasma Pneumonia

Effect of Ambroxol Hydrochloride and Clenbuterol Hydrochloride Tablets Combined with Azithromycin Intervention on Anti-Inflammatory,proinflammatory Cytokines and Immune Function in Children with Mycoplasma Pneumonia

Clinical Efficacy of Azithromycin in the Treatment of Pediatric Mycoplasma pneumoniae Pneumonia and Its Impact on Platelet Count and D-Dimer Levels

Effect of azithromycin combined with ambroxol in children with Mycoplasma pneumoniae pneumonia

The change of asthma-associated immunological parameters in children with mycoplasma pneumoniae infection

Erythromycin Cydocarbonate improvement of clinical symptoms of mycoplasma pneumonia and analysis of immunoglobulin level changes and mechanism

Combined Treatment for Child Refractory Mycoplasma Pneumoniae Pneumonia with Ciprofloxacin and Glucocorticoid

Efficacy and safety of azithromycin combined with glucocorticoid on refractory Mycoplasma pneumoniae pneumonia in children

The Treatment Research of Quinolone Using in Children Refractory Mycoplasma Pneumonia

Efficacy and safety of Azithromycin and Erythromycin for respiratory mycoplasma infection in children: a meta-analysis

Efficacy of Azithromycin plus Glucocorticoid Adjuvant Therapy on Serum Inflammatory Factor Levels and Incidence of Adverse Reactions in Children with Mycoplasma Pneumonia

The Effect of Azithromycin in Treating Mycoplasma Pneumonia in Children

Comparison of azithromycin and erythromycin in the treatment of mycoplasma pneumonia in children

The Timing Of Azithromycin Treatment Is Not Associated With The Clinical Prognosis Of Childhood Mycoplasma Pneumoniae Pneumonia In High Macrolide-Resistant Prevalence Settings

Analysis of the Efficacy of Erythromycin Cyclic 11,12-Carbonate Combined with Azithromycin in the Treatment of Severe Mycoplasma Pneumoniae Pneumonia in Children and its Effect on Cytokines

Meta-analysis of combined azithromycin and inhaled budesonide treatment for Chinese pediatric patients with mycoplasma pneumonia

Multi-center study of the combination of traditional Chinese medicine and western methods treatment in the mycoplasma pneumoniae lower respiratory infection in children

Mixed infections in children with Mycoplasma pneumonial pneumonia